Acute effects of β1-selective and nonselective β-adrenergic receptor blockade on cardiac sympathetic activity in congestive heart failure

Circulation

Volumn 94, Issue 3, 1996, Pages 353-358

  Newton, Gary E ^a   Parker, John D ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

Author keywords

heart failure; nervous system, autonomic; norepinephrine; adrenergic antagonists

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; METOPROLOL; NORADRENALIN; PROPRANOLOL;

ADRENERGIC TRANSMISSION; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; CATECHOLAMINE BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; DOSE RESPONSE; DRUG SELECTIVITY; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0029815997     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.94.3.353     Document Type: Article

References (43)

1. Hasking GJ, Esler MD, Jennings GJ, Burton D, Johns JA, Korner PI. Norepinephrine spillover to plasma in patients with congestive heart failure: evidence of increased overall and cardiorenal sympathetic nervous activity. Circulation. 1986;73:615-621.
2. Conn JN, Levine TB, Olivari MT, Garberg V, Tura D, Francis GS, Simon AB, Rector T. Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure. N Engl J Med. 1984;311:819-823.
3. Kaye DM, Lefkovits J, Jennings GL, Bergin P, Broughton A, Esler MD. Adverse consequences of high sympathetic nervous activity in the failing human heart. J Am Coll Cardiol. 1995;26:1257-1263.
4. 1-receptor down-regulation in heart failure. Circ Res. 1986;59:297-309.
5. Mann DL, Kent RL, Parsons B, Cooper G. Adrenergic effects on the biology of the adult mammalian cardiocyte. Circulation. 1992; 85:790-804.
6. Meredith IT, Broughton A, Jennings GL, Esler MD. Evidence of a selective increase in cardiac sympathetic activity in patients with sustained ventricular arrhythmias. N Engl J Med. 1991;325:618-624.
7. Parker JD, Newton GE, Landzberg JS, Floras JS, Colucci WS. Functional significance of presynaptic α-adrenergic receptors in the failing and nonfailing human left ventricle. Circulation. 1995;92:1793-1800.
8. Adler-Graschinsky E, Langer SZ. Possible role of a β-adrenoreceptor in the regulation of noradrenaline release by nerve stimulation through a positive feed-back mechanism. Br J Pharmacol. 1975;53: 43-50.
9. Majewski H. Modulation of noradrenaline release through activation of presynaptic β-adrenoreceptors. J Auton Phannacol. 1983;3:47-60.
10. Misu Y, Kubo T. Presynaptic β-adrenoreceptors. Med Res Rev. 1986; 6:197-225.
11. Boudreau G, Peronnet F, De Champlain J, Nadeau R. Presynaptic effects of epinephrine on norepinephrine release from cardiac sympathetic nerves in dogs. Am J Physiol. 1993;265:H205-H211.
12. 2adrenoreceptor subtypes in canine intrathoracic efferent sympathetic nervous system regulating the heart. Am J Physiol. 1991;261:R1269-R1275.
13. Huang MH, Smith FM, Armour JA. Modulation of in situ canine intrinsic cardiac neuronal activity by nicotinic, muscarinic, and βadrenergic agonists. Am J Physiol. 1993;265:R659-R669.
14. Esler M, Jennings G, Korner P, Blombery P, Sacharias N, Leonard P. Measurement of total and organ-specific norepinephrine kinetics in humans. Am J Physiol. 1984;247:E21-E28.
15. Mathey DG, Chatterjee K, Tyberg JV, Lekven J, Brundage B, Parmeley WW. Coronary sinus reflux: a source of error in the measurement of thermodilution coronary sinus flow. Circulation. 1971;57: 778-786.
16. Ganz W, Tamura K, Marcus HS, Donoso R, Swan HJC. Measurement of coronary sinus blood flow by continuous thermodilution in man. Circulation. 1971;44:181-195.
17. Sundlof G, Wallin BG, Stromgren E, Nerhed C. Acute effects of metoprolol on muscle sympathetic activity in hypertensive humans. Hypertension. 1983;5:749-756.
18. Thoren PN. Characteristics of left ventricular receptors with non-medullated vagal afferents in cats. Circ Res. 1977;40:415-421.
19. Floras JS. Epinephrine and the genesis of hypertension. Hypertension. 1992;19:1-18.
20. Yamaguchi N, Naud M, Lamontagne D, Nadeau R, De Champlain J. Presynaptic inhibitory effects of sotalol, propranolol, and acebutolol on noradrenaline release upon cardiac sympathetic nerve stimulation in anaesthetized dogs. Can J Physiol Pharmacol. 1986;64: 1076-1084.
21. Foucart S, Nadeau R, De Champlain J. Local modulation of adrenal catecholamines release by beta-2 adrenoceptors in the anaesthetized dog. Naunyn Schmiedebergs Arch Pharmacol. 1988;337:29-34.
22. Coltart DJ, Meldrum SJ. The effect of propranolol on the human and canine transmembrane action potential. Br J Pharmacol. 1970;40:148P.
23. Wallin BG, Sundlof G, Stromgren E, Aberg H. Sympathetic outflow to muscles during treatment of hypertension with metoprolol. Hypertension. 1984;6:557-562.
24. Rahman MA, Hara K, Daly PA, Wigle ED, Floras JS. Reductions in muscle sympathetic nerve activity after long term metoprolol for dilated cardiomyopathy: preliminary observations. Br Heart J. 1995; 74:431-436.
25. Persson B, Andersson OK, Hjemdahl P, Wysocki M, Agerwall S, Waliin G. Adrenaline infusion in man increases muscle sympathetic nerve activity and noradrenaline overflow to plasma. J Hypertens. 1989;7:747-756.
26. Vincent HH, Man In't Veld AJ, Boomsma F, Wenting GJ, Schalekamp MADH. Elevated plasma noradrenaline in response to β-adrenoceptor stimulation in man. Br J Pharmacol. 1982;13: 717-721.
27. Floras JS, Aylward PE, Victor RG, Mark AL, Abboud FM. Epinephrine facilitates neurogenic vasoconstriction in humans. J Clin Invest. 1988;81:1265-1274.
28. Chang PC, Grossman E, Kopin IJ, Goldstein DS. On the existence of functional beta-adrenoceptors on vascular sympathetic nerve endings in the human forearm. J Hypertens. 1994;12:681-690.
29. Yamaguchi N, De Champlain J, Nadeau RA. Regulation of norepinephrine release from cardiac sympathetic fibers in the dog by presynaptic α- and β-receptors. Circ Res. 1977;41:108-117.
30. Cousineau D, Goresky CA, Bach GG, Rose CP. Effect of β-adrenergic blockade on in vivo norepinephrine release in canine heart. Am J Physiol 1984;246:H283-H292.
31. 3αH]noradrenaline kinetics during adrenaline infusion in man. Clin Sci. 1991;80:227-233.
32. 1,-adrenoceptor blockade in man. Clin Sci. 1993;84:413-417.
33. Swedberg K, Hjalmarson A, Waagstein F, Wallentin I. Beneficial effects of long-term beta-blockade in congestive cardiomyopathy. Br Heart J. 1980;44;117-133.
34. Packer M, Bristow MR, Cohn JN, Colucci WS, Fowler MB, Gilbert EM. Effect of carvedilol on the survival of patients with chronic heart failure. Circulation. 1995;92(suppl I):I-142. Abstract.
35. Waagstein F, Bristow MR, Swedberg K, Camerini F, Fowler MB, Silver MA, Gilbert EM, Johnson MR, Goss FG, Hjalmarson A. Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Lancet. 1994;342:1441-1446.
36. Eichorn EJ, Hjalmarson A. β-Blocker therapy for chronic heart failure: the frog prince. Circulation. 1994;90:2153-2156.
37. Gilbert EM, Anderson JL, Deitchman D, Yanowitz FG, O'Connell JB, Renlund DG, Bartholomew M, Mealey PC, Larrabee P, Bristow MR. Long-term β-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo. Am J Med. 1990;88:223-229.
38. Woodley SL, Gilbert EM, Anderson JL, O'Connell JB, Dietchman D, Yanowitz FG, Mealey PC, Volkman K, Renlund DG, Menlove R, Bristow MR. β-Blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy. Circulation. 1991;84:2426-2441.
39. Andersson B, Lomsky M, Waagstein F. The link between acute haemodynamic adrenergic beta-blockade and long-term effects in patients with heart failure: a study on diastolic function, heart rate and myocardial metabolism following intravenous metoprolol. Eur Heart J. 1993;14:1375-1385.
40. Eichorn EJ, Heesch CM, Barnett JH, Alvarez LG, Pass SM, Grayburn PA, Hatfield A, Marcoux LG, Malloy CR. Effect of metoprolol on myocardial function and energetics in patients with nonischemic dilated cardiomyopathy: a randomized, double-blind placebo-controlled study. J Am Coll Cardiol. 1994;24:1310-1320.
41. Andersson B, Hamm C, Persson S, Wikstrom G, Sinagra G, Hjalmarson A, Waagstein F. Improved exercise hemodynamic status in dilated cardiomyopathy after beta-adrenergic blockade treatment. J Am Coll Cardiol. 1994;23:1397-1404.
42. Paolisso G, Gambardella A, Marrazzo G, Verza M, Teasuro P, Varricchio M, D'Onofrio F. Metabolic and cardiovascular benefits derived from β-adrenergic blockade in chronic congestive heart failure. Am Heart J. 1992;123:103-110.
43. Esler M, Jennings G, Korner P, Willett I, Dudley F, Anderson W, Lambert G. Assessment of human sympathetic nervous system activity from measurements of norepinephrine turnover. Hypertension. 1988;11:3-20.